ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 170 filers reported holding ASCENDIS PHARMA A/S in Q3 2021. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $18,034,000 | +2822.9% | 113,146 | +2311.5% | 0.08% | +2466.7% |
| Q2 2021 | $617,000 | -97.3% | 4,692 | -97.3% | 0.00% | -96.8% |
| Q1 2021 | $22,775,000 | -49.1% | 176,712 | -34.1% | 0.10% | -53.4% |
| Q4 2020 | $44,713,000 | +37.1% | 268,098 | +26.8% | 0.20% | -2.4% |
| Q3 2020 | $32,625,000 | +46.6% | 211,414 | +40.5% | 0.21% | +42.2% |
| Q2 2020 | $22,258,000 | +8.9% | 150,491 | -17.1% | 0.15% | -5.2% |
| Q1 2020 | $20,440,000 | -68.8% | 181,511 | -61.5% | 0.16% | -51.1% |
| Q4 2019 | $65,612,000 | -17.8% | 471,619 | -43.1% | 0.32% | -30.2% |
| Q3 2019 | $79,802,000 | -20.7% | 828,512 | -5.2% | 0.45% | -27.2% |
| Q2 2019 | $100,600,000 | -63.2% | 873,645 | -62.4% | 0.62% | -35.6% |
| Q1 2019 | $273,412,000 | +487.6% | 2,322,952 | +212.7% | 0.97% | +115.3% |
| Q4 2018 | $46,534,000 | -53.3% | 742,759 | -47.2% | 0.45% | +31.2% |
| Q3 2018 | $99,642,000 | +134.2% | 1,406,174 | +119.9% | 0.34% | +42.9% |
| Q2 2018 | $42,543,000 | +13.6% | 639,547 | +11.6% | 0.24% | +27.7% |
| Q1 2018 | $37,466,000 | +155.4% | 572,871 | +56.4% | 0.19% | +132.1% |
| Q4 2017 | $14,672,000 | -10.3% | 366,244 | -19.4% | 0.08% | -22.1% |
| Q3 2017 | $16,361,000 | +235.1% | 454,485 | +160.7% | 0.10% | +188.9% |
| Q2 2017 | $4,882,000 | -2.8% | 174,354 | -2.8% | 0.04% | -10.0% |
| Q1 2017 | $5,022,000 | – | 179,355 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 7,387,900 | $1,177,557,000 | 16.32% |
| Q Global Advisors, LLC | 66,714 | $10,634,000 | 8.85% |
| Ghost Tree Capital, LLC | 120,000 | $19,127,000 | 5.59% |
| Vivo Capital, LLC | 760,606 | $121,233,000 | 5.44% |
| Spyglass Capital Management LLC | 1,378,887 | $219,781,000 | 5.04% |
| Avoro Capital Advisors LLC | 1,980,000 | $315,592,000 | 4.96% |
| Eversept Partners, LP | 445,203 | $70,960,906 | 4.93% |
| Sofinnova Investments, Inc. | 499,824 | $79,667,000 | 4.72% |
| Eventide Asset Management | 1,748,648 | $278,717,000 | 3.68% |
| Baker Brothers Advisors | 4,541,604 | $723,886,000 | 3.18% |